Aspergillus tubingensis: a major filamentous fungus found in the airways of patients with lung disease

• Published in: Medical mycology (Oxford) Vol. 54; no. 5; pp. 459 - 470
• Main Authors: Gautier, Magali, Normand, Anne-Cécile, L'Ollivier, Coralie, Cassagne, Carole, Reynaud-Gaubert, Martine, Dubus, Jean-Christophe, Brégeon, Fabienne, Hendrickx, Marijke, Gomez, Carine, Ranque, Stéphane, Piarroux, Renaud
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 01-07-2016
• Subjects: Adolescent; Adult; Aged; Antifungal Agents - pharmacology; Aspergillosis - microbiology; Aspergillosis - pathology; Aspergillus - drug effects; Aspergillus - isolation & purification; Aspergillus tubingensis; Child; Child, Preschool; Female; Human health and pathology; Humans; Infant; Infectious diseases; Life Sciences; Lung Diseases - complications; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult; colonization; human; cystic fibrosis; aspergillosis; chronic obstructive pulmonary disease
• ISSN: 1369-3786; 1460-2709; 1365-280X
• DOI: 10.1093/mmy/myv118

The black Aspergillus group comprises A. niger and 18 other species, which are morphologically indistinguishable. Among this species subset, A. tubingensis, described in less than 30 human cases before 2014, is primarily isolated from ear, nose, and throat samples. Recently, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry has emerged as a powerful technique to identify microbes in diagnostic settings. We applied this method to identify 1,720 filamentous fungi routinely isolated from clinical samples our laboratory over a two-year study period. Accordingly, we found 85 isolates of A. niger, 58 of A. tubingensis, and six other black Aspergillus (4 A. carbonarius and 2 A. japonicus). A. tubingensis was the fifth most frequent mold isolated in our mycology laboratory, primarily isolated from respiratory samples (40/58 isolates). In this study, we mainly aimed to describe the clinical pattern of Aspergillus tubingensis.
We analyzed the clinical features of the patients in whom A. tubingensis had been isolated from 40 respiratory samples. Thirty patients suffered from cystic fibrosis, chronic obstructive pulmonary disease or other types of chronic respiratory failure. Strikingly, 20 patients were experiencing respiratory acute exacerbation at the time the sample was collected. Antifungal susceptibility testing of 36 A. tubingensis isolates showed lower amphotericin B MICs (P < 10−4) and higher itraconazole and voriconazole MICs (P < 10−4 and P = .0331, respectively) compared with 36 A. niger isolates. Further studies are required to better establish the role that this fungus plays in human diseases, especially in the context of cystic fibrosis and chronic pulmonary diseases.